학술논문

A Phase 2a Study of Nilotinib in Participants with Advanced and Early Parkinson's Disease. Study Design
Document Type
Journal
Source
ANNALS OF NEUROLOGY; OCT 2017, 82 pS186-pS186, 1p. Supplement: 21
Subject
Language
English
ISSN
15318249